Literature DB >> 15488956

Differential impairments of facial affect recognition in schizophrenia subtypes and major depression.

Godehard Weniger1, Claudia Lange, Eckart Rüther, Eva Irle.   

Abstract

The goal of this study was to assess facial affect recognition abilities in subjects with various schizophrenia subtypes and subjects with major depression. A total of six disorganized, 21 paranoid and 18 residual subjects with schizophrenia (DSM-IV criteria) were compared with 21 subjects with major depression (DSM-IV criteria) and 30 matched healthy control subjects. Two experimental tasks requiring the sorting and rating of emotional facial expressions were applied. Disorganized and paranoid subjects showed strong impairments in the sorting of emotional facial expressions. Depressive subjects displayed only minor deficits, and residual subjects were unimpaired. Subjects with disorganized schizophrenia rated emotional facial expressions as more aroused, and depressive subjects rated them as less aroused, than the other study groups. Our study demonstrates strong deficits in facial affect recognition in subjects with schizophrenia and pronounced disorganized or psychotic symptoms. Deficits in facial affect recognition are specific to schizophrenia. They may be considered as a state marker of schizophrenia.

Entities:  

Mesh:

Year:  2004        PMID: 15488956     DOI: 10.1016/j.psychres.2003.12.027

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  20 in total

1.  Facial emotion perception in schizophrenia: Does sex matter?

Authors:  Jasmine Mote; Ann M Kring
Journal:  World J Psychiatry       Date:  2016-06-22

Review 2.  [Expression, identification and experience of emotions in mental diseases. An overview].

Authors:  K Wolf; R Maß; M Lambert; K Wiedemann; D Naber
Journal:  Nervenarzt       Date:  2014-03       Impact factor: 1.214

Review 3.  Stem cell-based models and therapies: a key approach into schizophrenia treatment.

Authors:  Bagher Larijani; Peyvand Parhizkar Roudsari; Mahdieh Hadavandkhani; Sepideh Alavi-Moghadam; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Forough Azam Sayahpour; Fereshteh Mohamadi-Jahani; Babak Arjmand
Journal:  Cell Tissue Bank       Date:  2021-01-02       Impact factor: 1.522

4.  Symptom domains and neurocognitive functioning can help differentiate social cognitive processes in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Rachel C Wood; Gerhard S Hellemann
Journal:  Schizophr Bull       Date:  2011-07-15       Impact factor: 9.306

5.  Identifying differences in biased affective information processing in major depression.

Authors:  Jackie K Gollan; Heather T Pane; Michael S McCloskey; Emil F Coccaro
Journal:  Psychiatry Res       Date:  2008-03-14       Impact factor: 3.222

6.  Facial emotion perception in schizophrenia: a meta-analytic review.

Authors:  Christian G Kohler; Jeffrey B Walker; Elizabeth A Martin; Kristin M Healey; Paul J Moberg
Journal:  Schizophr Bull       Date:  2009-03-27       Impact factor: 9.306

Review 7.  Neurocognition and symptoms identify links between facial recognition and emotion processing in schizophrenia: meta-analytic findings.

Authors:  Joseph Ventura; Rachel C Wood; Amy M Jimenez; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2013-11-21       Impact factor: 4.939

Review 8.  [Social cognition in patients with mood disorders: part I: major depressive disorder : a comprehensive review of the literature].

Authors:  Christine Maria Hörtnagl; Stefan Oberheinricher; Alex Hofer
Journal:  Neuropsychiatr       Date:  2014-06-11

9.  Deficits in facial emotion recognition in schizophrenia: a replication study with korean subjects.

Authors:  Seung Jae Lee; Hae-Kook Lee; Yong-Sil Kweon; Chung Tai Lee; Kyoung-Uk Lee
Journal:  Psychiatry Investig       Date:  2010-11-23       Impact factor: 2.505

10.  Is There Any Relation Between Impaired Emotion Perception and Thought Disorder in Schizophrenia?

Authors:  Elif Yildirim; Berna Yalinçetin; Şilay Sevilmiş; Özge Kutay; Köksal Alptekin
Journal:  Noro Psikiyatr Ars       Date:  2018-05-04       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.